Breaking the “Medical Bypass”: New Drugs to Combat Obesity
The depiction of Santa Claus as a large, overweight figure reinforces the idea that being overweight is acceptable, and this is a concerning message to send to the public. The recent development of anti-obesity drugs that are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries is a promising development in the fight against obesity. These drugs, such as Eli Lilly’s Mounjaro (tirzepatide) and Novo Nordisk’s CagriSema (semaglutide + cagrilintide), have the potential to help millions of people suffering from obesity, but access to these drugs is still limited due to slow uptake from private health insurers and other barriers. It is important that we continue to work towards making anti-obesity drugs more accessible and that we challenge the idea that being overweight is acceptable.
Gr8 news! This is really promosing. I wonder if these drugs are going to be affordable for those who need them? It’s a shame that private health insurers are not taking them up faster.
It’s great to see new drugs to combat obesity. Hopefully they will become more accessible soon so more people can benefit from them.
This is a great development and I hope it helps to reduce the prevalence of obesity. Santa Claus should be depicted as a healthy weight so we can promote healthy body images.
This is an important step in the fight against obesity. However, it is not enough. We need the UN to intervene and set regulations to make sure anti-obesity drugs are more accessible and affordable.